Savilahti E, Brandtzaeg P, Kuitunen P
Gastroenterology. 1980 Dec;79(6):1303-10.
The clinical course of alpha-chain disease in a Finnish boy is described. The disease presented with growth retardation and gastrointestinal symptoms at age 10 yr. Tests performed between the ages of 15 and 21 yr showed varying intestinal involvement including the large bowel, ileum, and distal jejunum. Alpha-chain disease protein was present in serum in fluctuating concentrations for at least 5 yr; it was produced by plasmacytoid cells found in the affected parts of the large bowel mucosa. The patient was treated with sulfasalazine and melphalan, but it is not clear that the clinical remission and the subsequent disappearance of the alpha-chain disease protein should be ascribed to this treatment. Concomitant with the normalization of the condition, a selective immunoglobulin A deficiency became apparent. The possibility is raised that an immunoglobulin A deficiency could have been the original defect in the patient, predisposing to intestinal infections; topical overstimulation of a defective immunoglobulin A system due to impaired mucosal defense might thus have explained the emergence of alpha-chain disease cells in the gut.
本文描述了一名芬兰男孩的α链病临床病程。该疾病在患儿10岁时表现为生长发育迟缓及胃肠道症状。15至21岁期间进行的检查显示肠道受累情况各异,累及大肠、回肠和空肠远端。α链病蛋白在血清中的浓度波动至少持续了5年;它由在大肠黏膜受累部位发现的浆细胞样细胞产生。患者接受了柳氮磺胺吡啶和美法仑治疗,但尚不清楚临床缓解以及随后α链病蛋白的消失是否应归因于这种治疗。随着病情恢复正常,选择性免疫球蛋白A缺乏变得明显。由此提出一种可能性,即免疫球蛋白A缺乏可能是该患者的原始缺陷,使其易患肠道感染;由于黏膜防御受损导致有缺陷的免疫球蛋白A系统局部过度刺激,可能因此解释了肠道中α链病细胞的出现。